Document Detail

UK Renal Registry 13th Annual Report (December 2010): Chapter 9: haemoglobin, ferritin and erythropoietin amongst UK adult dialysis patients in 2009: national and centre-specific analyses.
MedLine Citation:
PMID:  21894032     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: The UK Renal Association (RA) and National Institute for Health and Clinical Excellence (NICE) have published Clinical Practice Guidelines which include recommendations for management of anaemia in established renal failure.
AIMS: To determine the extent to which the guidelines for anaemia management are met in the UK.
METHODS: Quarterly data were obtained regarding haemoglobin (Hb) and factors that influence Hb from renal centres in England, Wales, Northern Ireland (EWNI) and the Scottish Renal Registry for the incident and prevalent renal replacement therapy (RRT) cohorts for 2009.
RESULTS: In the UK, in 2009 55% of patients commenced dialysis therapy with Hb x10.0 g/dl (median Hb 10.2 g/dl). The median Hb of haemodialysis (HD) patients was 11.6 g/dl with an interquartile range (IQR) of 10.6 - 12.4 g/dl. Of HD patients 85% had Hb ≥ 10.0 g/dl. The median Hb of peritoneal dialysis (PD) patients in the UK was 11.7 g/dl (IQR 10.7-12.6 g/dl). Of UK PD patients, 88% had Hb ≥ 10.0 g/dl. The median ferritin in HD patients in EWNI was 441 mg/L (IQR 289-629) and 96% of HD patients had a ferritin ≥ 100 mg/L. The median ferritin in PD patients was 249 mg/L (IQR 142-412) with 86% of PD patients having a ferritin 5100 mg/L. In EWNI the mean Erythropoietin Stimulating Agent (ESA) dose was higher for HD than PD patients (9,507 vs. 6,212 IU/week).
CONCLUSIONS: In 2009, 56% of prevalent HD patients had a Hb ≥ 10.5 and ≤ 12.5 g/dl compared with 54% in 2008 and 53% in 2007. Fifty-four percent of prevalent PD patients had a Hb ≥10.5 and ≤12.5 g/dl compared to 55% in 2008.
Julie Gilg; Lynsey Webb; Terry Feest; Damian Fogarty
Publication Detail:
Type:  Comparative Study; Journal Article; Multicenter Study     Date:  2011-08-26
Journal Detail:
Title:  Nephron. Clinical practice     Volume:  119 Suppl 2     ISSN:  1660-2110     ISO Abbreviation:  Nephron Clin Pract     Publication Date:  2011  
Date Detail:
Created Date:  2011-09-06     Completed Date:  2012-06-22     Revised Date:  2014-07-30    
Medline Journal Info:
Nlm Unique ID:  101159763     Medline TA:  Nephron Clin Pract     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  c149-77     Citation Subset:  IM    
Copyright Information:
Copyright © 2011 S. Karger AG, Basel.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Ambulatory Care Facilities* / trends
Anemia / epidemiology,  therapy
Annual Reports as Topic
Cohort Studies
Erythropoietin / blood*,  therapeutic use
Ferritins / blood,  therapeutic use*
Great Britain / epidemiology
Hemoglobins / metabolism,  therapeutic use*
Kidney Failure, Chronic / blood,  epidemiology,  therapy*
Middle Aged
Renal Dialysis / methods*
Young Adult
Reg. No./Substance:
0/EPO protein, human; 0/Hemoglobins; 11096-26-7/Erythropoietin; 9007-73-2/Ferritins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  UK Renal Registry 13th Annual Report (December 2010): Chapter 8: adequacy of haemodialysis in UK adu...
Next Document:  Chapter 10: Calcium, Phosphate, Parathyroid Hormone, Bicarbonate and Total Cholesterol Concentration...